Non-Clinical Health & Environmental Safety Studies
🌱 Visnova Insights: Ensuring Safety Beyond the Clinic – The
Role of Non-Clinical Health & Environmental Safety Studies
📘 Introduction
In pharmaceutical and agrochemical
research, non-clinical health and environmental safety studies are
essential. They ensure that new drugs and chemicals are safe for both human and
environmental health—before they ever reach clinical trials. These
studies follow Good Laboratory Practice (GLP) to guarantee scientific
accuracy and regulatory compliance.
🔬 Table 1: Overview of Non-Clinical Safety Studies
Purpose |
Examples |
Outcome/Use |
Identify toxic effects |
Acute, sub-chronic, chronic
toxicity tests |
Determine organ-specific toxicity |
Establish exposure limits |
Dose-response studies |
Identify NOAEL
(No-Observed-Adverse-Effect Level) |
Study metabolism and kinetics |
ADME studies (Absorption,
Distribution, Metabolism, Excretion) |
Understand drug movement and
breakdown |
Reproductive & developmental
toxicity |
Fertility, embryo-fetal
development studies |
Evaluate impact on reproduction |
Genetic toxicity |
Ames test, Micronucleus test |
Detect potential mutagenic
properties |
🌍 Table 2: Types of Environmental Safety Studies
Study
Type |
Key
Focus |
Measured
Parameters |
Significance |
Environmental Fate |
Degradation in soil, water, air |
DT50, DT90, Half-life |
Predicts persistence in
environment |
Ecotoxicology |
Effect on fish, daphnia, algae |
LC50, EC50, NOEC |
Assesses toxicity to non-target
organisms |
Bioaccumulation |
Chemical accumulation in living
tissues |
BAF, BCF |
Estimates long-term ecological
risk |
Mobility in Soil |
Movement of substance through soil |
Koc (Adsorption Coefficient) |
Evaluates groundwater
contamination risk |
🏛 Table 3: GLP Regulatory Compliance Across Regions
Region |
Regulatory
Authority |
GLP
Guidelines Followed |
Applicable
Sectors |
USA |
US FDA, US EPA |
21 CFR Part 58, FIFRA GLP Rules |
Pharma, Environment, Pesticides |
Europe |
EMA, ECHA |
OECD Principles of GLP |
Pharma, Agrochemicals |
India |
NGCMA (DSIR), MoEFCC |
OECD-GLP via NABL recognition |
Pharma, Agrochemicals, Environment |
Japan |
PMDA, MHLW |
OECD GLP + Local Ministry
Guidelines |
Pharmaceuticals |
🧩
Table 4: Visnova’s Support for Non-Clinical Studies
Area
of Expertise |
Services
Provided |
Target
Clients |
Lab Setup & Infrastructure |
Layout planning, Equipment
selection, Documentation |
New CROs, QA Units |
GLP Training |
SOP writing, QA/QC training, GLP
documentation practices |
Analysts, Study Directors, QA
personnel |
Regulatory Documentation |
Study plan design, Report
formatting, Archival guidance |
CROs, Regulatory teams |
Mock Audits & Prechecks |
Compliance review, Gap analysis,
Remedial actions |
Labs seeking NABL/OECD
certification |
📣 Connect with Visnova
For consultations, training, or lab
setup in non-clinical and environmental safety testing:
📧 Email: poornachandrashetty@visnovacom.com
🌐 Website: Coming Soon!
Comments
Post a Comment